Hengyuan Li

机构：Second Affiliated Hospital of Zhejiang University, Zhejiang University · ORCID：0000-0002-5913-1414

发表论文 125 篇 · 总被引 2198 次 · h-index 27

代表论文

• The role of mitochondria in tumor metastasis and advances in mitochondria-targeted cancer therapy (2024 · Cancer and Metastasis Reviews · 被引 46)
• ZIF‐8‐Encapsulated Pexidartinib Delivery via Targeted Peptide‐Modified M1 Macrophages Attenuates MDSC‐Mediated Immunosuppression in Osteosarcoma (2024 · Small · 被引 23)
• Selective promotion of sensory innervation–mediated immunoregulation for tissue repair (2025 · Science Advances · 被引 13)
• 609O CLDN18.2 targeted antibody-drug conjugate (ADC), SHR-A1904, in patients (pts) with gastric/gastroesophageal junction cancer (GC/GEJC): A phase I study (2024 · Annals of Oncology · 被引 10)
• Natural lung-tropic T H 9 cells: a sharp weapon for established lung metastases (2024 · Journal for ImmunoTherapy of Cancer · 被引 6)
• Outcomes in non‐small cell lung cancer with uncommon epidermal growth factor receptor L858 substitutions under first‐line epidermal growth factor receptor tyrosine kinase inhibitors: A large real‐world cohort study (2024 · Cancer Science · 被引 4)